Michele T. Cooper

发表

Monitoring PDT response of head and neck lesions with diffuse optical spectroscopies

Barbara W. Henderson, Heinz Baumann, Ulas Sunar, 2013, Photonics West - Biomedical Optics.

Photodynamic therapy with 3‐(1′‐hexyloxyethyl) pyropheophorbide‐a for early‐stage cancer of the larynx: Phase Ib study

Barbara W. Henderson, Gal Shafirstein, Wei Tan, 2015, Head & neck.

Interlesion differences in the local photodynamic therapy response of oral cavity lesions assessed by diffuse optical spectroscopies

Ulas Sunar, Barbara W. Henderson, Heinz Baumann, 2012, Biomedical optics express.

Cutaneous phototoxic occurrences in patients receiving Photofrin®

Michele T. Cooper, T J Dougherty, T. Mang, 1990, Lasers in surgery and medicine.

Use of Photodynamic Therapy for the Treatment of Extensive Basal Cell Carcinomas

Michele T. Cooper, T. Mang, H. Stoll, 1989, Facial plastic surgery : FPS.

Photodynamic Therapy with 3-(1′-Hexyloxyethyl) Pyropheophorbide a for Cancer of the Oral Cavity

Ulas Sunar, Heinz Baumann, Maureen Sullivan, 2013, Clinical Cancer Research.

Monitoring photobleaching and hemodynamic responses to HPPH-mediated photodynamic therapy of head and neck cancer: a case report.

Daniel Rohrbach, Ulas Sunar, Heinz Baumann, 2010, Optics express.

Cross-Linking of Signal Transducer and Activator of Transcription 3—A Molecular Marker for the Photodynamic Reaction in Cells and Tumors

Heinz Baumann, Erin Tracy, Michele T. Cooper, 2007, Clinical Cancer Research.

Preliminary clinical data on a new photodynamic therapy photosensitizer: 2-[1-hexyloxyethyl]-2-devinylpyropheophorbide-a (HPPH) for treatment of obstructive esophageal cancer

Hector R. Nava, Thomas J. Dougherty, Michele T. Cooper, 2000, BiOS.

Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with barrett's esophagus

Michele T. Cooper, T. Dougherty, B. Henderson, 2011, Lasers in surgery and medicine.

Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate.

Michele T. Cooper, W R Greco, D Babich, 2000, Cancer research.

Photodynamic therapy for the treatment of basal cell carcinoma.

Michele T. Cooper, T J Dougherty, T. Mang, 1992, Archives of dermatology.

Adjuvant intraoperative photodynamic therapy in head and neck cancer.

Michele T. Cooper, B. Henderson, G. Wilding, 2013, JAMA otolaryngology-- head & neck surgery.

Photodynamic therapy for head and neck dysplasia and cancer.

Michele T. Cooper, Michele Cooper, Krishnakumar Thankappan, 2009, Archives of otolaryngology--head & neck surgery.

Advances in Brief Photofrin Photodynamic Therapy Can Significantly Deplete or Preserve Oxygenation in Human Basal Cell Carcinomas during Treatment , Depending on Fluence Rate 1

Michele T. Cooper, B. Henderson, A. Oseroff, 2000 .

A dose ranging study of photodynamic therapy with porfimer sodium (Photofrin®) for treatment of basal cell carcinoma

Michele T. Cooper, Michele Cooper, T. Mang, 2006, Lasers in surgery and medicine.

Cross-Linking of SignalTransducer and Activator of Transcription 3 AMolecular Marker for the Photodynamic Reaction in Cells andTumors

Michele T. Cooper, B. Henderson, H. Baumann, 2007 .